Actics Medical
Transforming Diabetic Care – Saving Limbs and Lives with AI-Powered, Remote Proactive Therapy
Company Overview
Snapshot
Founded in October 2020 by Ron Machanian, Actics Medical operates with 1–10 employees. The company has raised $1.3M across three funding rounds. In June 2025, Actics Medical secured Pre-Seed funding from embARC Ventures.
Business overview
Actics Medical is a Health Tech & Life Sciences company focused on redefining diabetic foot care through an AI-powered platform for continuous monitoring and personalized intervention. Its core product, the Hybrid+™ smart insole, integrates real-time pressure, temperature, and gait sensing with adaptive offloading. The company serves the healthcare industry, targeting insurance companies, providers, and patients, with a vision to expand into orthopedics and neurology.
Strategic signal
Actics Medical is preparing for significant market validation, with clinical trials scheduled to launch in early 2026 with a major US health system. This strategic move indicates a strong pathway toward commercial adoption and demonstrates the company's commitment to proving the efficacy of its AI-powered smart insoles in a clinical setting, signaling potential for substantial growth and market penetration.
Log in to access full profile ›Company Intelligence Q&A
- When was Actics Medical founded?
- Actics Medical was founded in October 2020.
- Who is the founder of Actics Medical?
- Ron Machanian is the Founder & CEO of Actics Medical.
- What is Actics Medical's primary product?
- Actics Medical's primary product is the Hybrid+™ smart insole, which combines real-time pressure, temperature, and gait sensing with adaptive offloading for diabetic foot care.
- What is the status of Actics Medical's product development?
- Actics Medical's Hybrid+™ smart insole is currently in the clinical trial stage, with trials expected to launch in early 2026 with a major US health system.
- Which investor participated in Actics Medical's Pre-Seed funding round in June 2025?
- In June 2025, Actics Medical secured Pre-Seed funding from embARC Ventures. This round was part of a total of $1.3M raised across three funding rounds by the company.